Ridge Expansion by Osseodensification Simultaneously With Implant Placement in Narrow Alveolar Ridges
1 other identifier
interventional
20
1 country
1
Brief Summary
Narrow alveolar ridges with a thickness equal or less than 5 mm requires bone augmentation procedures before or at the time of implant placement. (Anitua, Begoña, and Orive 2013) Several surgical techniques have been utilized for the reconstruction of deficient alveolar ridges such as block onlay graft augmentation, guided bone regeneration, distraction osteogenesis , ridge splitting and/or ridge expansion(McAllister and Haghighat 2007). A new bone drilling technique named Osseodensification facilitates horizontal ridge expansion. Studies are needed to validate the effectiveness of osseodensification as a lateral ridge augmentation procedure that aims at increasing the thickness of atrophic ridges, thus maintaining ridge integrity and allowing for implant placement with enhanced stability. The null hypothesis Proposes no difference in the bone width gain following the osseodensification drilling system compared to the ridge splitting technique with simultaneously placed implants in narrow alveolar ridges.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 25, 2018
CompletedFirst Posted
Study publicly available on registry
July 19, 2018
CompletedStudy Start
First participant enrolled
August 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2019
CompletedJuly 31, 2018
July 1, 2018
6 months
June 25, 2018
July 29, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Change in bone width
Using Cone beam computed tomography bone width gain will be reported in millimeters.
Baseline and six month post surgically
Secondary Outcomes (5)
Change in Implant stability Quotients
at the time of surgery and 6 month post surgical
soft tissue healing at 1 week using the Healing index by Landry,Turnbull and Howley (1988) to describe the extent of clinical healing after periodontal surgery.
1 week post surgically.
soft tissue healing at 2 weeks using the Healing index by Landry,Turnbull and Howley 1988 to describe the extent of clinical healing after periodontal surgery.
2 weeks post surgically
Changes in Crestal Bone level
at the time of enrollment and 6 month post surgically
Pain scale using the numerical Visual analog scale.
1 week post surgically
Study Arms (2)
Ridge expansion by osseodensification
EXPERIMENTALRidge expansion and osteotomy drilling by osseodensification in conjunction with simultaneous implant placement in narrow ridges.
Ridge expansion by ridge splitting
ACTIVE COMPARATORRidge expansion by ridge splitting using the piezotome in conjunction with simultaneous implant placement in narrow ridges.
Interventions
Osseodensification is a new concept facilitated by Densah® Burs which are a multi- fluted osteotome like drilling instrumentsThe idea behind the technique is using a non-subtractive drilling mode that preserves bone and increases its density along the osteotomy walls instead of cutting it away (Huwais and Meyer 2015)
using the piezotome,Piezoelectric ridge splitting allows exact, clean, and smooth even curved cutting of the bone tissue, with proper visibility.
Eligibility Criteria
You may qualify if:
- Patients with at least one missing tooth in need of replacement.
- Patients having a Bucco-lingual/palatal width of the edentulous alveolar ridge less than 6 mm with a minimum of 3mm residual bone width.
- Patients having at least 11 mm residual bone height at the proposed edentulous area.
- The recipient bed of the implant should be free from any pathological conditions.
- No history of diagnosed bone disease or medication known to affect bone metabolism.
- Patients who are cooperative, motivated, and hygiene conscious.
You may not qualify if:
- Patients incapable to undergoing minor oral surgical procedures.
- Patients with insufficient vertical inter-arch space, upon centric occlusion, to accommodate the available restorative components.
- Patients who have any systemic condition that may contraindicate implant therapy.
- Patients with modifying habits affecting osteointegration for example, smoking and alcoholism.
- Patients with parafunctional habits that can overload the implant, such as bruxism and clenching.
- Patients with impractical expectations about the esthetic outcome of implant therapy.
- Patients in the growth stage with mixed dentition.
- Patients with a history of drug abuse.
- Patients with a history of psychiatric disorder.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
The Faculty of Dentistry -Cairo University
Cairo, Egypt
Study Officials
- PRINCIPAL INVESTIGATOR
Radwa A ElMaghrabi, BSC
Cairo University
- STUDY DIRECTOR
Amr zahran, PHD
Cairo University
- STUDY CHAIR
Ahmed Al barbary, PHD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 25, 2018
First Posted
July 19, 2018
Study Start
August 30, 2018
Primary Completion
March 1, 2019
Study Completion
March 1, 2019
Last Updated
July 31, 2018
Record last verified: 2018-07